Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults

NCT04989972 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped GCP VIOLATIONS FROM THE SPONSORS

Conditions

Anxiety and Depression

Interventions

DRUG: PSIL428
DIETARY_SUPPLEMENT: Oyster mushroom
DRUG: PSIL428

Sponsor

Wake Network, Inc.

Collaborators

[object Object]